FDA

Page 3 of 35

The DOGE-fueled firing of AI experts at the FDA endangers lives and worsens the hospital crisis
Commentary

The DOGE-fueled firing of AI experts at the FDA endangers lives and worsens the hospital crisis

By
February 27, 2025
Robert F. Kennedy Jr.
Health

With RFK Jr. in charge, supplement makers see chance to cash in

By KFF Health News and Arthur Allen
February 25, 2025
The outside of the FDA headquarters
Politics

Market Analyst

By Matthew Perrone and The Associated Press
February 24, 2025
Semaglutide medications Wegovy and Ozempic are pictured
Health

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi Kresge
February 21, 2025
A woman takes pills at her desk
Health

The dietary supplements you think are improving your health may be damaging your liver, research warns

By
February 19, 2025
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
Health

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products

By Matthew Perrone and The Associated Press
February 17, 2025
A woman holds a medicine bottle while reading instructions.
Health

Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive

By
February 15, 2025
Doctor analyzes health care data
Health

Judge tells CDC, FDA to restore webpages and data removed after Trump’s executive order

By The Associated Press and Michael Kunzelman
February 11, 2025
A woman injects herself with medication.
Health

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

By
February 11, 2025
A young woman undergoes a brain scan.

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith
January 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By
January 29, 2025
Eli Lilly & Co., the Coins2Day 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
woman pouring milk from one container into another outside, with a cow in the background
Health

Raw milk, touted by RFK Jr. and costing up to $21 a gallon, is under fire because of bird flu. What science says about the benefits and risks

By
January 17, 2025

Most Popular